Click here for printer friendly page
Brook Venture Partners closes $100m fund24/01/2007. Source: AltAssets. 
 Brook Venture Partners, a US-based provider of capital to expansion stage companies, has closed its second fund, Brook Venture Fund II, on $100m. The fund will make investments in select IT and Medical Technology companies throughout the Northeast.
Investors in the new fund include the State of Pennsylvania, State of Vermont, Finance Authority of Maine, Bank North, Merrill Lynch, Brooke Private Equity and Green Stamps America.
Investments made by Brook II to date include Repromedix Corp., Wandrian, HistoRx, and Anodyne Health Partners.
'Young companies increasingly need expansion stage capital and welcome Brook's investment approach,' said Andrew Clapp, partner with Brook. 'Brook fills the gap between the smaller, individual investors who top out at around $1m, and larger private equity players who typically invest far more than $5m per deal. We provide that critical $2-5m piece that can accelerate a young company's growth.'
Copyright © 2007 AltAssets
|
